Avastin for PDR (Proliferative Diabetic Retinopathy)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Elliott Sohn, University of Southern California

ClinicalTrials.gov Identifier:

NCT01270542

First received: December 1, 2010

Last updated: January 16, 2013

Last verified: January 2013

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	July 2012
Primary Completion Date:	July 2011 (Final data collection date for primary outcome measure)

No publications provided by University of Southern California

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Sohn EH, He S, Kim LA, Salehi-Had H, Javaheri M, Spee C, Dustin L, Hinton DR, Eliott D. Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1. Arch Ophthalmol. 2012 Sep 1;130(9):1127-34. doi: 10.1001/archophthalmol.2012.1611.

To Top